Skip to main content
Erschienen in: Reactions Weekly 1/2016

01.11.2016 | Case report

Antineoplastics/dexamethasone

Septic shock secondary to yeast infection: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Sun W, et al. Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia. Pediatric Blood and Cancer 63: 1943-1948, No. 11, Nov 2016. Available from: URL: http://doi.org/10.1002/pbc.26129 - USACrossRefPubMed Sun W, et al. Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia. Pediatric Blood and Cancer 63: 1943-1948, No. 11, Nov 2016. Available from: URL: http://​doi.​org/​10.​1002/​pbc.​26129 - USACrossRefPubMed
Metadaten
Titel
Antineoplastics/dexamethasone
Septic shock secondary to yeast infection: case report
Publikationsdatum
01.11.2016
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-22767-8

Weitere Artikel der Ausgabe 1/2016

Reactions Weekly 1/2016 Zur Ausgabe

Case report

Clozapine

Case report

Metformin

Case report

Bleomycin